Table 1. A summary of se veral CA subtypes, associated OMIM number, mutated genes, and function of the affected protein.
Disease | OMIM | Gene | Protein function |
---|---|---|---|
ADCAs | |||
Repeat expansions in exons
| |||
DRPLA | 125370 | ATN1 | Transcriptional corepressor |
HD | 143100 | HTT | Microtubule-mediated vesicle transport |
HDL1 | 603218 | PRNP | Copper iron; microtubule binding |
HDL2 | 606438 | JPH3 | Calcium-release channel activity |
SCA1 | 164400 | ATXN1 | Nucleic acid binding |
SCA17/HDL4 | 607136 | TBP | Transcription factor |
SCA2 | 183090 | ATXN2 | RNA binding |
SCA3 | 109150 | ATXN3 | Deubiquitinating enzyme |
SCA6 | 183086 | CACNA1A | Voltage-gated calcium channel |
SCA7 | 164500 | ATXN7 | Chromatin binding |
Repeat expansions in noncoding regions
| |||
SCA10 | 603516 | ATXN10 | Unknown |
SCA12 | 604326 | PPP2R2B | Protein phosphatase |
SCA31 | 117210 | BEAN1 | Unknown |
SCA36 | 614153 | NOP56 | Ribosomal RNA subunit biogenesis |
SCA8 | 608768 | ATXN8OS | Noncoding gene |
Missense, nonsense, insertion, or deletion mutations
| |||
ADCA-DN | 604121 | DNMT1 | DNA methyltransferase |
CANPMR | 614756 | CAMTA1 | Transcriptional activator |
Cortical myoclonus | 614937 | NOL3 | RNA binding |
Familiar dementia | 176500 | ITM2B | ATP; beta amyloid binding |
Gillespie syndrome | 206700 | PAX6 | Transcription factor |
SCA5 | 600224 | SPTBN2 | Cytoskeleton component |
SCA11 | 604432 | TTBK2 | Protein kinase |
SCA13 | 605259 | KCNC3 | Voltage-gated potassium channel |
SCA14 | 605361 | PRKCG | Calcium-dependent protein kinase |
SCA15/SCA16 | 606658 | ITPR1 | Ligand-gated calcium channel |
SCA19/SCA22 | 607346 | KCND3 | Voltage-gated potassium channel |
SCA23 | 610245 | PDYN | Neuropeptide hormone activity |
SCA26 | 609306 | EEF2 | Translation factor |
SCA27 | 609307 | FGF14 | Growth factor |
SCA28 | 610246 | AFG3L2 | ATP-dependent protease |
SCA35 | 613908 | TGM6 | Protein crosslinking; polyamine conjugation |
ARCAs | |||
AOA1 | 208920 | APTX | DNA repair |
AOA2 | 606002 | SETX | DNA/RNA helicase |
AOA3 | 615217 | PIK3R5 | PI3K regulation |
Ataxia telangectasia | 208900 | ATM | DNA damage-dependent protein kinase |
Ataxia telangectasia-like disorder | 604391 | MRE11A | DNA repair |
Cayman | 601238 | ATCAY | Unknown |
Charlevoix-Saguenay | 270550 | SACS | Cochaperone |
Cockayne syndrome A | 216400 | ERCC8 | DNA repair; ubiquitin ligase complex component |
Cockayne syndrome B | 133540 | ERCC6 | DNA repair |
Coenzyme Q10 deficiency | 607426 | COQ2 | Coenzyme Q biosynthesis |
Friedreich ataxia | 229300 | FXN | Iron homeostasis |
Marinesco–Sjogren | 248800 | SIL1 | Protein translocation/folding |
MGA5 | 610198 | DNAJC19 | Protein translocation; cochaperone |
PHARC | 612674 | ABHD12 | Lipid hydrolysis |
SCAN1 | 607250 | TDP1 | DNA repair |
SCAR8 | 610743 | SYNE1 | Cytoskeleton |
SCAR9 | 612016 | CABC1 | Kinase; coenzyme Q biosynthesis |
Abbreviations: ADCAs, autosomal dominant cerebellar ataxias; ARCAs, autosomal recessive cerebellar ataxias; CA, cerebellar ataxia; DRPLA, dentatorubral pallidoluysian atrophy; HD, Huntington disease; SCA, spinocerebellar ataxia.